IL-6 expression induced by adenosine A2b receptor stimulation in U373 MG cells depends on p38 mitogen activated kinase and protein kinase C

被引:34
作者
Fiebich, BL
Akundi, RS
Biber, K
Hamke, M
Schmidt, C
Butcher, RD
van Calker, D
Willmroth, F
机构
[1] Univ Freiburg, Sch Med, Dept Psychiat & Psychotherapy, Neurochem Res Grp, D-79104 Freiburg, Germany
[2] Univ Groningen, Dept Med Physiol, Groningen, Netherlands
关键词
gene expression; cytokines; adenosine; astrocytes; camp; signal transduction;
D O I
10.1016/j.neuint.2004.11.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Adenosine binds to a class of G-protein coupled receptors, which are further distinguished as A1, A(2a), A(2b) and A(3) adenosine receptors. As we have shown earlier, the stable adenosine analogue NECA (N6-(R)-phenylisopropyladenosine) stimulates IL-6 expression in the human astrocytoma cell line U373 MG via the A(2b) receptor. The mechanism by which NECA promotes astrocytic IL-6 expression has not been identified. By using various inhibitors of signal transduction, we found that p38 mitogen-activated protein kinases (MAPK) activation (inhibitor SB202190), but not extracellular signal-regulated kinase (ERK) (PD98059) and c-jun N-terminal kinase (JNK)(SP600125), is essential in the NECA-induced signalling cascade that leads to the increase in IL-6 synthesis in U373 MG cells. Results obtained with protein kinase C (PKC) inhibitors that have different substrate specificities, indicated that the PKC delta and epsilon isoforms are also involved in adenosine receptor A(2b) dependent upregulation of IL-6 expression. This is supported by the fact that NECA induced the activation of PKC delta and epsilon in U373 MG cells. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:501 / 512
页数:12
相关论文
共 88 条
[1]   1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline-induced apoptosis in the human neuroblastoma cell line SK-N-SH [J].
Akundi, RS ;
Macho, A ;
Muñoz, E ;
Lieb, K ;
Bringmann, G ;
Clement, HW ;
Hüll, M ;
Fiebich, BL .
JOURNAL OF NEUROCHEMISTRY, 2004, 91 (02) :263-273
[2]   THE PARTICIPATION OF INTERLEUKIN-6 IN THE PATHOGENESIS OF ALZHEIMERS-DISEASE [J].
BAUER, J ;
GANTER, U ;
STRAUSS, S ;
STADTMULLER, G ;
FROMMBERGER, U ;
BAUER, H ;
VOLK, B ;
BERGER, M .
RESEARCH IN IMMUNOLOGY, 1992, 143 (06) :650-656
[3]   THE ACUTE-PHASE RESPONSE [J].
BAUMANN, H ;
GAULDIE, J .
IMMUNOLOGY TODAY, 1994, 15 (02) :74-80
[4]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[5]   Carbamazepine-induced upregulation of adenosine A1-receptors in astrocyte cultures affects coupling to the phosphoinositol signaling pathway [J].
Biber, K ;
Fiebich, BL ;
Gebicke-Härter, P ;
van Calker, D .
NEUROPSYCHOPHARMACOLOGY, 1999, 20 (03) :271-278
[6]  
Biber K, 1997, J NEUROSCI, V17, P4956
[7]   Interleukin-6 enhances expression of adenosine A1 receptor mRNA and signaling in cultured rat cortical astrocytes and brain slices [J].
Biber, K ;
Lubrich, B ;
Fiebich, BL ;
Boddeke, HWGM ;
van Calker, D .
NEUROPSYCHOPHARMACOLOGY, 2001, 24 (01) :86-96
[8]   Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway [J].
Blackburn, MR ;
Lee, CG ;
Young, HWJ ;
Zhu, Z ;
Chunn, JL ;
Kang, MJ ;
Banerjee, SK ;
Elias, JA .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (03) :332-344
[9]   CAMP IS NOT INVOLVED IN INTERLEUKIN-1-INDUCED INTERLEUKIN-6 RELEASE FROM HUMAN ASTROCYTOMA-CELLS [J].
CADMAN, ED ;
NAUGLES, DD ;
LEE, CM .
NEUROSCIENCE LETTERS, 1994, 178 (02) :251-254
[10]  
CADMAN ED, 1994, J NEUROCHEM, V63, P980